genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Venom Goes to Bat as Novel Medical Treatment
News
BMS Buyout Not Stopping Celgene from Launching Cancer Collaborations with Kyn,…
News
Obesity-Regulating Brain Signaling Pathway Genes Identified
News
Cancer Fighting T Cells Produced Continuously through New Method
News
Stem Cell Therapy Patch for Macular Degeneration Sees the Light of…
Insights
Insights
Literature Review: Advanced Biologic Therapies and Advanced Biologics Manufacturing
Insights
Top 10 Global Biopharma IPOs of 2018
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
A-Lists
Insights
Top 10 Global Biopharma IPOs of 2018
A-Lists
5 Biopharma Trends to Watch in 2019
A-Lists
Top 10 RNA-Based Biopharmas of 2018
Insights
Top 10 Molecular Millionaires of 2018
A-Lists
Top 10 Pharma Companies of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Venom Goes to Bat as Novel Medical Treatment
News
BMS Buyout Not Stopping Celgene from Launching Cancer Collaborations with Kyn,…
News
Obesity-Regulating Brain Signaling Pathway Genes Identified
News
Cancer Fighting T Cells Produced Continuously through New Method
Magazine
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
January 2019 Vol. 39 No. 1
PATH: New Organization Fostering AI, Automation and Healthcare
Resources
All
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Events
AACR Annual Meeting
Events
Circulating Biomarkers World Congress
Events
Bio Europe Spring
Events
Phar-East
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Cancer
Ovarian Cancer
Ovarian Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Ovarian Cancer
GSK to Acquire PARP Inhibitor Developer Tesaro for $5.1B
Ovarian Cancer
Anti-Cancer Drug Effects Measured at Single-Cell Level by Multidimensional Technique
Ovarian Cancer
Personalized Cancer Vaccine Shows Promise in Patients with Advanced Ovarian Cancer
Ovarian Cancer
Newly Uncovered Pathway Points to New Strategies Against Ovarian Cancer
Ovarian Cancer
Immunotherapy Raises the Stakes and Ovarian Cancer Blinks
Ovarian Cancer
BRCA1/2 Testing Protocols Vary Extensively Worldwide
Ovarian Cancer
Chemo Fails Reversed by Blocking Cancer Cells’ Toxin Pumps
Ovarian Cancer
Stanford Spinout Partners with Merck KGaA, Genentech in Cancer Studies of...
Ovarian Cancer
FDA, CMS Approve Foundation Medicine’s Solid Tumor Test with Proposed Coverage
Ovarian Cancer
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...
Ovarian Cancer
Discovery that Ovarian Cancer Originates in Fallopian Tubes May Aid Earlier...
Ovarian Cancer
Mateon Halts Lead Candidate Development, Axes 60% of Workforce
Ovarian Cancer
Novel Strategy Targets Cancer Cells While Sparing Normal Ones
Ovarian Cancer
PharmaMar Licenses Rights to Cancer Candidate for Southeast Asia, Australia
Ovarian Cancer
Clovis Partners with Myriad on Diagnostic for Ovarian Cancer Treatment
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![A genomic study suggests that most ovarian cancers originate in the fallopian tube. [Carolyn Hruban]](https://www.genengnews.com/wp-content/uploads/2018/08/Oct23_2017_CarolynHruban_OvarianCancer1585063111-324x160.jpg "Discovery that Ovarian Cancer Originates in Fallopian Tubes May Aid Earlier Diagnosis")
![Multidimensional analysis of PARP toxicity using automated high-content microscopy. Various key parameters of cellular responses are investigated. [University of Zurich]](https://www.genengnews.com/wp-content/uploads/2018/08/Jul11_2018_UnivZurich_EffectsOfDrugsOnCancerCells2521233144-265x198.jpg "Anti-Cancer Drug Effects Measured at Single-Cell Level by Multidimensional Technique")
